DiscoverAI in Life SciencesOpenstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal
Openstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal

Openstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal

Update: 2024-03-30
Share

Description

On the latest episode of "AI in Life Sciences," we engage with the impressive multimodal, AI-driven technology patented by Openstream.ai. This technology promises to revolutionize operational efficiency across multiple sectors with its advanced capabilities. Also, we discuss a breakthrough in the biopharma industry - an AI platform capable of identifying promising early-stage assets and firms. We also delve into the pressing need for the integration of AI technology in the healthcare sector for improved patient care and operational efficiency. We round up the episode examining the implications of Novo's $1 billion deal in the field of cardiovascular medicine, a move that could redefine the cardiac treatment landscape. Tune in for these exciting insights and more.
Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Openstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal

Openstream.ai's Digital Twin Revolution, Biopharma AI Breakthroughs, AI in Healthcare, and Novo's Billion Dollar Cardiac Deal

Stan Berteloot